The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

How Oral Targeted Therapies and IV Immunotherapies Disrupted Community Practice Financing

Barbara McAneny, MD
Published Online: 3:37 PM, Thu April 27, 2017

Barbara McAneny, MD, the chief executive officer of New Mexico Cancer Center, discusses how oral targeted therapies and immunotherapies disrupted the traditional methods for financing community practices.

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.